EUVIMEDDescoperă EUVIMED
Open access

Effectiveness of the Lilly Connected Care Program in Improving Glycemic Management Among Patients With Type 2 Diabetes in China: Retrospective Real-world Study

Benli Su iD, Yu Chen iD, Xingping Shen iD, Jianchao Guo iD, Yuchen Ding iD, Xiao Ma iD, Yuxin Yang iD, Dongfang Liu iD

Journal of Medical Internet Research · 2023-04-25 · 25 · e38680

DOI: 10.2196/38680 ↗

At a glance

Journal article in Journal of Medical Internet Research, published online on 2023-04-25. Written by Benli Su and 7 co-authors. Institution: Department of Endocrinology, The Second Hospital of Dalian Medical University, Dalian, China. Major MEDLINE topics: Diabetes Mellitus, Type 2. Cited 2 times so far (Crossref); 36 references. The full text is freely available in PubMed Central.

RezumatSubjectsDate bibliograficeCiteRelated studies

Abstract (original language)

Background

Type 2 diabetes mellitus (T2DM) is a worldwide public health concern. Mobile health management platforms could be a potential way to achieve effective glycemic control.

Objective

This study aimed to evaluate the real-world effectiveness of the Lilly Connected Care Program (LCCP) platform in glycemic control among patients with T2DM in China.

Methods

This retrospective study included Chinese patients with T2DM (aged ≥18 years) from April 1, 2017, to January 31, 2020, for the LCCP group and from January 1, 2015, to January 31, 2020, for the non-LCCP group. Propensity score matching was used to match the LCCP and non-LCCP groups to reduce confounding, with covariates including age, sex, the duration of diabetes, baseline hemoglobin A1c (HbA1c), and the number of oral antidiabetic medication classes. HbA1c reduction over 4 months, the proportions of patients achieving an HbA1c reduction of ≥0.5% or ≥1%, and the proportions of patients reaching to target HbA1c level of ≤6.5% or

Subjects

MeSH terms (MEDLINE)

Diabetes Mellitus, Type 2HumansAdolescentAdultRetrospective StudiesBlood GlucoseHypoglycemic AgentsInsulin

Author keywords

LCCPLilly Connected Care ProgramT2DMdiabetes managementhemoglobin A1creal-word studytype 2 diabetes mellitus

Substances

Blood GlucoseHypoglycemic AgentsInsulin

Authors and institutions

  • Department of Endocrinology, The Second Hospital of Dalian Medical University, Dalian, China.
  • Department of Endocrinology, The Second Hospital of Tianjin Medical University, Tianjin, China.
  • Department of Endocrinology, Zhongshan Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China.
  • Lilly Suzhou Pharmaceutical Co Ltd, Shanghai, China.
  • Department of Endocrinology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.

ORCID profiles: Benli Su, Yu Chen, Xingping Shen, Jianchao Guo, Yuchen Ding, Xiao Ma, Yuxin Yang, Dongfang Liu

Cite

APA

Su, B., Chen, Y., Shen, X., Guo, J., Ding, Y., Ma, X., Yang, Y., & Liu, D. (2023). Effectiveness of the Lilly Connected Care Program in Improving Glycemic Management Among Patients With Type 2 Diabetes in China: Retrospective Real-world Study. Journal of Medical Internet Research, 25, e38680. https://doi.org/10.2196/38680

Vancouver

Su B, Chen Y, Shen X, Guo J, Ding Y, Ma X, et al. Effectiveness of the Lilly Connected Care Program in Improving Glycemic Management Among Patients With Type 2 Diabetes in China: Retrospective Real-world Study. Journal of Medical Internet Research. 2023;25:e38680. doi:10.2196/38680

BibTeX
@article{Su2023,
  author = {Su, Benli and Chen, Yu and Shen, Xingping and Guo, Jianchao and Ding, Yuchen and Ma, Xiao and Yang, Yuxin and Liu, Dongfang},
  title = {Effectiveness of the Lilly Connected Care Program in Improving Glycemic Management Among Patients With Type 2 Diabetes in China: Retrospective Real-world Study},
  journal = {Journal of Medical Internet Research},
  year = {2023},
  volume = {25},
  pages = {e38680},
  doi = {10.2196/38680}
}
Start for free →